Prittle Prattle Pr

Mankind Pharma Reports ₹3,570 Cr Revenue in Q1FY26, Grows 24.5% YoY with 23.8% EBITDA Margin

Written by

admin

in

Mankind Pharma Reports ₹3,570 Cr Revenue in Q1FY26, Grows 24.5% YoY with 23.8% EBITDA Margin

BSV acquisition Mankind Pharma

Fri, 01 Aug 2025 09:27:17 +0000

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts